This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by D'Arpa, P. Articles by Liu, L. F. Search for Related Content PubMed PubMed Citation Articles by D'Arpa, P. Articles by Liu, L. F.

Involvement of Nucleic Acid Synthesis in Cell Killing Mechanisms of Topoisomerase Poisons¹

Department of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205

The primary cytotoxic mechanism of camptothecin has been proposed to involve an interaction between the replication machinery and the camptothecin-mediated topoisomerase I-DNA cleavable complex (Y. H. Hsiang, M. G. Lihou, and L. F. Liu, Cancer Res., 49:5077–5082, 1989). In the present study, we show that killing of V79 cells by the topoisomerase II poisons 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) and etoposide may involve ongoing RNA synthesis in addition to ongoing DNA synthesis. V79 cells synchronized by mitotic shake-off were treated with topoisomerase poisons in the presence of inhibitors of nucleic acid synthesis. S-Phase V79 cells were more sensitive to the topoisomerase I poison camptothecin and the topoisomerase II poison m-AMSA than G₁-phase cells. The greater sensitivity of S-phase cells to killing by m-AMSA and camptothecin was abolished during cotreatment, but not posttreatment, with aphidicolin, suggesting that ongoing DNA synthesis is involved in cell killing by both topoisomerase I and II poisons. Cotreatment with transcription inhibitors, such as 5,6-dichloro-1-ß-D-ribofuranosyl benzimidazole or cordycepin, partially protected cells from the cytotoxic effects of m-AMSA but had no effect on camptothecin-mediated cytotoxicity. These results suggest that ongoing RNA transcription may be involved in cell killing by topoisomerase II poisons but not topoisomerase I poisons. Cotreatment with camptothecin reduced m-AMSA-mediated cytotoxicity in G₁-phase V79 cells, suggesting a possible antagonism between topoisomerase I and II poisons. This antagonistic effect between topoisomerase I and II poisons could be explained by the strong inhibitory effect of camptothecin on RNA transcription.

¹ This work was supported by NIH Grants CA08788 and CA39662.

² To whom requests for reprints should be addressed, at Department of Biological Chemistry, Johns Hopkins University School of Medicine, 725 North Wolfe Street, Baltimore, MD 21205.

Received 2/ 6/90. Accepted 8/ 1/90.

This article has been cited by other articles:

				C.-P. Lin, Y. Ban, Y. L. Lyu, and L. F. Liu Proteasome-dependent Processing of Topoisomerase I-DNA Adducts into DNA Double Strand Breaks at Arrested Replication Forks J. Biol. Chem., October 9, 2009; 284(41): 28084 - 28092. [Abstract] [Full Text] [PDF]

				J. E. Deweese and N. Osheroff The DNA cleavage reaction of topoisomerase II: wolf in sheep's clothing Nucleic Acids Res., February 1, 2009; 37(3): 738 - 748. [Abstract] [Full Text] [PDF]

				L. S. Kurtzberg, T. Battle, C. Rouleau, R. G. Bagley, N. Agata, M. Yao, S. Schmid, S. Roth, J. Crawford, R. Krumbholz, et al. Bone marrow and tumor cell colony-forming units and human tumor xenograft efficacy of noncamptothecin and camptothecin topoisomerase I inhibitors Mol. Cancer Ther., October 1, 2008; 7(10): 3212 - 3222. [Abstract] [Full Text] [PDF]

				M. Galvez-Peralta, N. T. Dai, D. A. Loegering, K. S. Flatten, S. L. Safgren, J. M. Wagner, M. M. Ames, L. M. Karnitz, and S. H. Kaufmann Overcoming S-Phase Checkpoint-Mediated Resistance: Sequence-Dependent Synergy of Gemcitabine and 7-Ethyl-10-hydroxycamptothecin (SN-38) in Human Carcinoma Cell Lines Mol. Pharmacol., September 1, 2008; 74(3): 724 - 735. [Abstract] [Full Text] [PDF]

				F. Fala, W. L. Blalock, P. L. Tazzari, A. Cappellini, F. Chiarini, G. Martinelli, A. Tafuri, J. A. McCubrey, L. Cocco, and A. M. Martelli Proapoptotic Activity and Chemosensitizing Effect of the Novel Akt Inhibitor (2S)-1-(1H-Indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan2-amine (A443654) in T-Cell Acute Lymphoblastic Leukemia Mol. Pharmacol., September 1, 2008; 74(3): 884 - 895. [Abstract] [Full Text] [PDF]

				J. R. Pohlhaus, D. T. Long, E. O'Reilly, and K. N. Kreuzer The {varepsilon} Subunit of DNA Polymerase III Is Involved in the Nalidixic Acid-Induced SOS Response in Escherichia coli J. Bacteriol., August 1, 2008; 190(15): 5239 - 5247. [Abstract] [Full Text] [PDF]

				C.-P. Lin, Y. Ban, Y. L. Lyu, S. D. Desai, and L. F. Liu A Ubiquitin-Proteasome Pathway for the Repair of Topoisomerase I-DNA Covalent Complexes J. Biol. Chem., July 25, 2008; 283(30): 21074 - 21083. [Abstract] [Full Text] [PDF]

				A. M. Azarova, Y. L. Lyu, C.-P. Lin, Y.-C. Tsai, J. Y.-N. Lau, J. C. Wang, and L. F. Liu From the Cover: Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies PNAS, June 26, 2007; 104(26): 11014 - 11019. [Abstract] [Full Text] [PDF]

				A. Zhang, Y. L. Lyu, C.-P. Lin, N. Zhou, A. M. Azarova, L. M. Wood, and L. F. Liu A Protease Pathway for the Repair of Topoisomerase II-DNA Covalent Complexes J. Biol. Chem., November 24, 2006; 281(47): 35997 - 36003. [Abstract] [Full Text] [PDF]

				S. F. El-Khamisy and K. W. Caldecott TDP1-dependent DNA single-strand break repair and neurodegeneration Mutagenesis, July 1, 2006; 21(4): 219 - 224. [Abstract] [Full Text] [PDF]

				P. Luo, Q. He, X. He, Y. Hu, W. Lu, Y. Cheng, and B. Yang Potent antitumor activity of 10-methoxy-9-nitrocamptothecin. Mol. Cancer Ther., April 1, 2006; 5(4): 962 - 968. [Abstract] [Full Text] [PDF]

				Y. Otake, A. Mims, and D. J. Fernandes Merbarone Induces Activation of Caspase-Activated DNase and Excision of Chromosomal DNA Loops from the Nuclear Matrix Mol. Pharmacol., April 1, 2006; 69(4): 1477 - 1485. [Abstract] [Full Text] [PDF]

				C. Gomez-Manzano, M. M. Alonso, W.K. A. Yung, F. McCormick, D. T. Curiel, F. F. Lang, H. Jiang, B. N. Bekele, X. Zhou, R. Alemany, et al. Delta-24 Increases the Expression and Activity of Topoisomerase I and Enhances the Antiglioma Effect of Irinotecan Clin. Cancer Res., January 15, 2006; 12(2): 556 - 562. [Abstract] [Full Text] [PDF]

				X. Zhao, M. Malik, N. Chan, A. Drlica-Wagner, J.-Y. Wang, X. Li, and K. Drlica Lethal Action of Quinolones against a Temperature-Sensitive dnaB Replication Mutant of Escherichia coli Antimicrob. Agents Chemother., January 1, 2006; 50(1): 362 - 364. [Abstract] [Full Text] [PDF]

				M. D. Gray, M. Mann, J. L. Nitiss, and L. M. Hendershot Activation of the Unfolded Protein Response Is Necessary and Sufficient for Reducing Topoisomerase II{alpha} Protein Levels and Decreasing Sensitivity to Topoisomerase-Targeted Drugs Mol. Pharmacol., December 1, 2005; 68(6): 1699 - 1707. [Abstract] [Full Text] [PDF]

				A. K. McClendon, A. C. Rodriguez, and N. Osheroff Human Topoisomerase II{alpha} Rapidly Relaxes Positively Supercoiled DNA: IMPLICATIONS FOR ENZYME ACTION AHEAD OF REPLICATION FORKS J. Biol. Chem., November 25, 2005; 280(47): 39337 - 39345. [Abstract] [Full Text] [PDF]

				S.-J. Shih, T. Erbele, and A. Y. Chen Ku86 Modulates DNA Topoisomerase I-Mediated Radiosensitization, but not Cytotoxicity, in Mammalian Cells Cancer Res., October 15, 2005; 65(20): 9194 - 9199. [Abstract] [Full Text] [PDF]

				M. T. Tomicic, M. Christmann, and B. Kaina Topotecan-Triggered Degradation of Topoisomerase I Is p53-Dependent and Impacts Cell Survival Cancer Res., October 1, 2005; 65(19): 8920 - 8926. [Abstract] [Full Text] [PDF]

				E. Bilsland and J. A. Downs Tails of histones in DNA double-strand break repair Mutagenesis, May 1, 2005; 20(3): 153 - 163. [Abstract] [Full Text] [PDF]

				A. Y. Chen, S.-J. Shih, L. N. Garriques, M. L. Rothenberg, M. Hsiao, and D. P. Curran Silatecan DB-67 is a novel DNA topoisomerase I-targeted radiation sensitizer Mol. Cancer Ther., February 1, 2005; 4(2): 317 - 324. [Abstract] [Full Text] [PDF]

				J. C. Game, M. S. Williamson, and C. Baccari X-Ray Survival Characteristics and Genetic Analysis for Nine Saccharomyces Deletion Mutants That Show Altered Radiation Sensitivity Genetics, January 1, 2005; 169(1): 51 - 63. [Abstract] [Full Text] [PDF]

				L. Catley, Y.-T. Tai, R. Shringarpure, R. Burger, M. T. Son, K. Podar, P. Tassone, D. Chauhan, T. Hideshima, L. Denis, et al. Proteasomal Degradation of Topoisomerase I Is Preceded by c-Jun NH2-Terminal Kinase Activation, Fas Up-Regulation, and Poly(ADP-Ribose) Polymerase Cleavage in SN38-Mediated Cytotoxicity against Multiple Myeloma Cancer Res., December 1, 2004; 64(23): 8746 - 8753. [Abstract] [Full Text] [PDF]

				A. Y. Chen, S.-J. Shih, M. Hsiao, M. L. Rothenberg, and M. Prudhomme Induction of Radiosensitization by Indolocarbazole Derivatives: The Role of DNA Topoisomerase I Mol. Pharmacol., September 1, 2004; 66(3): 553 - 560. [Abstract] [Full Text] [PDF]

				T. M. C. Yung, M. Parent, E. L. Y. Ho, and M. S. Satoh Camptothecin-sensitive Relaxation of Supercoiled DNA by the Topoisomerase I-like Activity Associated with Poly(ADP-ribose) Polymerase-1 J. Biol. Chem., March 19, 2004; 279(12): 11992 - 11999. [Abstract] [Full Text] [PDF]

				W. D. Block, Y. Yu, and S. P. Lees-Miller Phosphatidyl inositol 3-kinase-like serine/threonine protein kinases (PIKKs) are required for DNA damage-induced phosphorylation of the 32 kDa subunit of replication protein A at threonine 21 Nucleic Acids Res., February 10, 2004; 32(3): 997 - 1005. [Abstract] [Full Text] [PDF]

				M. Malik and J. L. Nitiss DNA Repair Functions That Control Sensitivity to Topoisomerase-Targeting Drugs Eukaryot. Cell, February 1, 2004; 3(1): 82 - 90. [Abstract] [Full Text] [PDF]

				H. Interthal, P. M. Quigley, W. G. J. Hol, and J. J. Champoux The Role of Lysine 532 in the Catalytic Mechanism of Human Topoisomerase I J. Biol. Chem., January 23, 2004; 279(4): 2984 - 2992. [Abstract] [Full Text] [PDF]

				T.-K. Li, P. J. Houghton, S. D. Desai, P. Daroui, A. A. Liu, E. S. Hars, A. L. Ruchelman, E. J. LaVoie, and L. F. Liu Characterization of ARC-111 as a Novel Topoisomerase I-Targeting Anticancer Drug Cancer Res., December 1, 2003; 63(23): 8400 - 8407. [Abstract] [Full Text] [PDF]

				E. R. Parrilla-Castellar and L. M. Karnitz Cut5 Is Required for the Binding of Atr and DNA Polymerase {alpha} to Genotoxin-damaged Chromatin J. Biol. Chem., November 14, 2003; 278(46): 45507 - 45511. [Abstract] [Full Text] [PDF]

				M. S. Kim, M. Blake, J. H. Baek, G. Kohlhagen, Y. Pommier, and F. Carrier Inhibition of Histone Deacetylase Increases Cytotoxicity to Anticancer Drugs Targeting DNA Cancer Res., November 1, 2003; 63(21): 7291 - 7300. [Abstract] [Full Text] [PDF]

				G. Hong and K. N. Kreuzer Endonuclease cleavage of blocked replication forks: An indirect pathway of DNA damage from antitumor drug-topoisomerase complexes PNAS, April 29, 2003; 100(9): 5046 - 5051. [Abstract] [Full Text] [PDF]

				S. D. Desai, H. Zhang, A. Rodriguez-Bauman, J.-M. Yang, X. Wu, M. K. Gounder, E. H. Rubin, and L. F. Liu Transcription-Dependent Degradation of Topoisomerase I-DNA Covalent Complexes Mol. Cell. Biol., April 1, 2003; 23(7): 2341 - 2350. [Abstract] [Full Text] [PDF]

				J.-Y. Chang, J.-F. Liu, S.-H. Juang, T.-W. Liu, and L.-T. Chen Novel Mutation of Topoisomerase I in Rendering Cells Resistant to Camptothecin Cancer Res., July 1, 2002; 62(13): 3716 - 3721. [Abstract] [Full Text] [PDF]

				T. Kobayashi, S. Tada, T. Tsuyama, H. Murofushi, M. Seki, and T. Enomoto Focus-formation of replication protein A, activation of checkpoint system and DNA repair synthesis induced by DNA double-strand breaks in Xenopus egg extract J. Cell Sci., January 8, 2002; 115(15): 3159 - 3169. [Abstract] [Full Text] [PDF]

				E. U. Kurz, S. E. Wilson, K. B. Leader, B. P. Sampey, W. P. Allan, J. C. Yalowich, and D. J. Kroll The Histone Deacetylase Inhibitor Sodium Butyrate Induces DNA Topoisomerase II{alpha} Expression and Confers Hypersensitivity to Etoposide in Human Leukemic Cell Lines Mol. Cancer Ther., December 1, 2001; 1(2): 121 - 131. [Abstract] [Full Text] [PDF]

				A. M. Wilstermann and N. Osheroff Base Excision Repair Intermediates as Topoisomerase II Poisons J. Biol. Chem., November 30, 2001; 276(49): 46290 - 46296. [Abstract] [Full Text] [PDF]

				J. R. Vance and T. E. Wilson Repair of DNA Strand Breaks by the Overlapping Functions of Lesion-Specific and Non-Lesion-Specific DNA 3' Phosphatases Mol. Cell. Biol., November 1, 2001; 21(21): 7191 - 7198. [Abstract] [Full Text] [PDF]

				P. Pichierri, A. Franchitto, R. Piergentili, C. Colussi, and F. Palitti Hypersensitivity to camptothecin in MSH2 deficient cells is correlated with a role for MSH2 protein in recombinational repair Carcinogenesis, November 1, 2001; 22(11): 1781 - 1787. [Abstract] [Full Text] [PDF]

				S. D. Desai, T.-K. Li, A. Rodriguez-Bauman, E. H. Rubin, and L. F. Liu Ubiquitin/26S Proteasome-mediated Degradation of Topoisomerase I As a Resistance Mechanism to Camptothecin in Tumor Cells Cancer Res., August 1, 2001; 61(15): 5926 - 5932. [Abstract] [Full Text] [PDF]

				P. Pichierri, A. Franchitto, P. Mosesso, and F. Palitti Werner's Syndrome Protein Is Required for Correct Recovery after Replication Arrest and DNA Damage Induced in S-Phase of Cell Cycle Mol. Biol. Cell, August 1, 2001; 12(8): 2412 - 2421. [Abstract] [Full Text] [PDF]

				L. Taricani, H. E. Feilotter, C. Weaver, and P. G. Young Expression of hsp16 in response to nucleotide depletion is regulated via the spc1 MAPK pathway in Schizosaccharomyces pombe Nucleic Acids Res., July 15, 2001; 29(14): 3030 - 3040. [Abstract] [Full Text] [PDF]

				B. A. Stohr and K. N. Kreuzer Repair of Topoisomerase-Mediated DNA Damage in Bacteriophage T4 Genetics, May 1, 2001; 158(1): 19 - 28. [Abstract] [Full Text]

				M. Fujishiro, T. Shinkai, M. Fukuda, T. Tamura, Y. Ohe, H. Kunitoh, Y. Nishiwaki, I. Sekine, H. Fukuda, and N. Saijo Phase I Study of a Weekly Infusion of Irinotecan Hydrochloride (CPT-11) and a 14-day Continuous Infusion of Etoposide in Patients with Lung Cancer: JCOG Trial 9408 Jpn. J. Clin. Oncol., November 1, 2000; 30(11): 487 - 493. [Abstract] [Full Text] [PDF]

				R van Gijn, R. Lendfers, J. Schellens, A Bult, and J. Beijnen Dual topoisomerase I/II inhibitors Journal of Oncology Pharmacy Practice, September 1, 2000; 6(3): 92 - 108. [Abstract] [PDF]

				Y. Mao, S. Okada, L.-S. Chang, and M. T. Muller p53 Dependence of Topoisomerase I Recruitment in Vivo Cancer Res., August 1, 2000; 60(16): 4538 - 4543. [Abstract] [Full Text]

				D. Strumberg, A. A. Pilon, M. Smith, R. Hickey, L. Malkas, and Y. Pommier Conversion of Topoisomerase I Cleavage Complexes on the Leading Strand of Ribosomal DNA into 5'-Phosphorylated DNA Double-Strand Breaks by Replication Runoff Mol. Cell. Biol., June 1, 2000; 20(11): 3977 - 3987. [Abstract] [Full Text]

				S. Sharma and L. B. Saltz Oral Chemotherapeutic Agents for Colorectal Cancer Oncologist, April 1, 2000; 5(2): 99 - 107. [Abstract] [Full Text]

				T. T. Huang, S. M. Wuerzberger-Davis, B. J. Seufzer, S. D. Shumway, T. Kurama, D. A. Boothman, and S. Miyamoto NF-kappa B Activation by Camptothecin. A LINKAGE BETWEEN NUCLEAR DNA DAMAGE AND CYTOPLASMIC SIGNALING EVENTS J. Biol. Chem., March 24, 2000; 275(13): 9501 - 9509. [Abstract] [Full Text] [PDF]

				M. Fujishiro, T. Shinkai, M. Fukuda, T. Tamura, Y. Ohe, H. Kunitoh, H. Nishiwaki, I. Sekine, Y. Matsuno, M. Niimi, et al. Phase I Study of a Weekly Infusion of Irinotecan Hydrochloride (CPT-11) and a 14-day Continuous Infusion of Etoposide in Patients with Lung Cancer: Japan Clinical Oncology Group 9408 Jpn. J. Clin. Oncol., March 1, 2000; 30(3): 122 - 127. [Abstract] [Full Text] [PDF]

				G. Hong and K. N. Kreuzer An Antitumor Drug-Induced Topoisomerase Cleavage Complex Blocks a Bacteriophage T4 Replication Fork In Vivo Mol. Cell. Biol., January 15, 2000; 20(2): 594 - 603. [Abstract] [Full Text]

				P. Fiorani, J. F. Amatruda, A. Silvestri, R. H. Butler, M.-A. Bjornsti, and P. Benedetti Domain Interactions Affecting Human DNA Topoisomerase I Catalysis and Camptothecin Sensitivity Mol. Pharmacol., December 1, 1999; 56(6): 1105 - 1115. [Abstract] [Full Text]

				J. Thompson, E. O. George, C. A. Poquette, P. J. Cheshire, L. B. Richmond, S. S. N. de Graaf, M. Ma, C. F. Stewart, and P. J. Houghton Synergy of Topotecan in Combination with Vincristine for Treatment of Pediatric Solid Tumor Xenografts Clin. Cancer Res., November 1, 1999; 5(11): 3617 - 3631. [Abstract] [Full Text] [PDF]

				I. F. Pollack, M. Erff, D. Bom, T. G. Burke, J. T. Strode, and D. P. Curran Potent Topoisomerase I Inhibition by Novel Silatecans Eliminates Glioma Proliferation in Vitro and in Vivo Cancer Res., October 1, 1999; 59(19): 4898 - 4905. [Abstract] [Full Text] [PDF]

				T.-K. Li and L. F. Liu Modulation of Gyrase-Mediated DNA Cleavage and Cell Killing by ATP Antimicrob. Agents Chemother., May 1, 1998; 42(5): 1022 - 1027. [Abstract] [Full Text]

				C. Hann, D. L. Evans, J. Fertala, P. Benedetti, M.-A. Bjornsti, and D. J. Hall Increased Camptothecin Toxicity Induced in Mammalian Cells Expressing Saccharomyces cerevisiae DNA Topoisomerase I J. Biol. Chem., April 3, 1998; 273(14): 8425 - 8433. [Abstract] [Full Text] [PDF]

				S. D. Desai, L. F. Liu, D. Vazquez-Abad, and P. D'Arpa Ubiquitin-dependent Destruction of Topoisomerase I Is Stimulated by the Antitumor Drug Camptothecin J. Biol. Chem., September 26, 1997; 272(39): 24159 - 24164. [Abstract] [Full Text] [PDF]

				M. D. Megonigal, J. Fertala, and M.-A. Bjornsti Alterations in the Catalytic Activity of Yeast DNA Topoisomerase I Result in Cell Cycle Arrest and Cell Death J. Biol. Chem., May 9, 1997; 272(19): 12801 - 12808. [Abstract] [Full Text] [PDF]

				D. S. Park, E. J. Morris, L. A. Greene, and H. M. Geller G1/S Cell Cycle Blockers and Inhibitors of Cyclin-Dependent Kinases Suppress Camptothecin-Induced Neuronal Apoptosis J. Neurosci., February 15, 1997; 17(4): 1256 - 1270. [Abstract] [Full Text] [PDF]

				P. S. Kingma, A. H. Corbett, P. C. Burcham, L. J. Marnett, and N. Osheroff Abasic Sites Stimulate Double-stranded DNA Cleavage Mediated by Topoisomerase II J. Biol. Chem., September 15, 1995; 270(37): 21441 - 21444. [Abstract] [Full Text] [PDF]

				A. M. Knab, J. Fertala, and M.-A. Bjornsti A Camptothecin-resistant DNA Topoisomerase I Mutant Exhibits Altered Sensitivities to Other DNA Topoisomerase Poisons J. Biol. Chem., March 17, 1995; 270(11): 6141 - 6148. [Abstract] [Full Text] [PDF]

				S. H. Elsea, Y. Hsiung, J. L. Nitiss, and N. Osheroff A Yeast Type II Topoisomerase Selected for Resistance to Quinolones J. Biol. Chem., January 27, 1995; 270(4): 1913 - 1920. [Abstract] [Full Text] [PDF]

				W Ongkeko, D. Ferguson, A. Harris, and C Norbury Inactivation of Cdc2 increases the level of apoptosis induced by DNA damage J. Cell Sci., January 8, 1995; 108(8): 2897 - 2904. [Abstract] [PDF]

				G. C. Ireton, L. Stewart, L. H. Parker, and J. J. Champoux Expression of Human Topoisomerase I with a Partial Deletion of the Linker Region Yields Monomeric and Dimeric Enzymes That Respond Differently to Camptothecin J. Biol. Chem., August 11, 2000; 275(33): 25820 - 25830. [Abstract] [Full Text] [PDF]

				Y.-Y. Mo, C. Wang, and W. T. Beck A Novel Nuclear Localization Signal in Human DNA Topoisomerase I J. Biol. Chem., December 22, 2000; 275(52): 41107 - 41113. [Abstract] [Full Text] [PDF]

				Y. Mao, S. D. Desai, C.-Y. Ting, J. Hwang, and L. F. Liu 26 S Proteasome-mediated Degradation of Topoisomerase II Cleavable Complexes J. Biol. Chem., October 26, 2001; 276(44): 40652 - 40658. [Abstract] [Full Text] [PDF]

				W. A. Cliby, K. A. Lewis, K. K. Lilly, and S. H. Kaufmann S Phase and G2 Arrests Induced by Topoisomerase I Poisons Are Dependent on ATR Kinase Function J. Biol. Chem., January 4, 2002; 277(2): 1599 - 1606. [Abstract] [Full Text] [PDF]

				Y. Mao, I. R. Mehl, and M. T. Muller Subnuclear distribution of topoisomerase I is linked to ongoing transcription and p53 status PNAS, February 5, 2002; 99(3): 1235 - 1240. [Abstract] [Full Text] [PDF]